Document ID: FDA-1999-N-0194-0008
Agency: fda
Document Type: Proposed Rule
Title: Additions and Modifications to the List of Drug Products That Have Been
Withdrawn or Removed From the Market for Reasons of Safety or
Effectiveness; Correction
Posted Date: 2014-11-17T05:00Z

[Federal Register Volume 79, Number 221 (Monday, November 17, 2014)]
[Proposed Rules]
[Page 68395]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27038]

[[Page 68395]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 216

[Docket No. FDA-1999-N-0194]
RIN 0910-AH08

Additions and Modifications to the List of Drug Products That 
Have Been Withdrawn or Removed From the Market for Reasons of Safety or 
Effectiveness; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; withdrawal of previous proposed rule; 
correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a 
document entitled ``Additions and Modifications to the List of Drug 
Products That Have Been Withdrawn or Removed From the Market for 
Reasons of Safety or Effectiveness'' that appeared in the Federal 
Register of July 2, 2014. The document proposed amending FDA's 
regulations to revise the list of drug products that may not be 
compounded under the exemptions provided by the Federal Food, Drug, and 
Cosmetic Act because the drug products have been withdrawn or removed 
from the market after the drug products or components of such drug 
products were found to be unsafe or not effective. The document also 
withdrew the previous proposed rule regarding additions to this list 
(see the Federal Register of January 4, 2000). The document was 
published with an incorrect RIN number. This document corrects the 
error.

DATES: The proposed rule published July 2, 2014 (79 FR 37687) is 
corrected as of November 17, 2014.

FOR FURTHER INFORMATION CONTACT: Edisa Gozun, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 51, Rm. 5199, Silver Spring, MD 20993-0002, 301-
796-3110.

SUPPLEMENTARY INFORMATION: In FR Doc. 2014-15371, appearing on page 
37687 in the Federal Register of July 2, 2014 (79 FR 37687), FDA is 
making the following correction:
    1. On page 37687, in the first column, the RIN number heading is 
corrected to read ``RIN 0910-AH08''.
    2. On page 37687, in the second column, the RIN number under the 
ADDRESSES heading is corrected to read ``RIN 0910-AH08''.
    3. On page 37687, in the second column, the RIN number under the 
Instructions sub-heading is corrected to read ``RIN 0910-AH08''.

    Dated: November 10, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-27038 Filed 11-14-14; 8:45 am]
BILLING CODE 4164-01-P